NASDAQ
Enzon Pharmaceuticals, Inc. (ENZN) has a current ratio of 58.57x as of Monday, May 25, 2026. This represents a 15.91% increase compared to its 12-month average of 50.53x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.